JP2017105802A5 - - Google Patents

Download PDF

Info

Publication number
JP2017105802A5
JP2017105802A5 JP2017012663A JP2017012663A JP2017105802A5 JP 2017105802 A5 JP2017105802 A5 JP 2017105802A5 JP 2017012663 A JP2017012663 A JP 2017012663A JP 2017012663 A JP2017012663 A JP 2017012663A JP 2017105802 A5 JP2017105802 A5 JP 2017105802A5
Authority
JP
Japan
Prior art keywords
vesicle
pharmaceutical composition
blood
polymer
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017012663A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017105802A (ja
JP6782415B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017105802A publication Critical patent/JP2017105802A/ja
Publication of JP2017105802A5 publication Critical patent/JP2017105802A5/ja
Application granted granted Critical
Publication of JP6782415B2 publication Critical patent/JP6782415B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017012663A 2013-11-22 2017-01-27 薬剤送達用のキャリア、コンジュゲートおよびこれらを含んでなる組成物並びにこれらの投与方法 Expired - Fee Related JP6782415B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2013242347 2013-11-22
JP2013242347 2013-11-22
JP2014096935 2014-05-08
JP2014096935 2014-05-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015548997A Division JP6086566B2 (ja) 2013-11-22 2014-11-21 薬剤送達用のキャリア、コンジュゲートおよびこれらを含んでなる組成物並びにこれらの投与方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019116818A Division JP2019194220A (ja) 2013-11-22 2019-06-25 薬剤送達用のキャリア、コンジュゲートおよびこれらを含んでなる組成物並びにこれらの投与方法

Publications (3)

Publication Number Publication Date
JP2017105802A JP2017105802A (ja) 2017-06-15
JP2017105802A5 true JP2017105802A5 (enExample) 2018-02-15
JP6782415B2 JP6782415B2 (ja) 2020-11-11

Family

ID=53179224

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015548997A Expired - Fee Related JP6086566B2 (ja) 2013-11-22 2014-11-21 薬剤送達用のキャリア、コンジュゲートおよびこれらを含んでなる組成物並びにこれらの投与方法
JP2017012663A Expired - Fee Related JP6782415B2 (ja) 2013-11-22 2017-01-27 薬剤送達用のキャリア、コンジュゲートおよびこれらを含んでなる組成物並びにこれらの投与方法
JP2019116818A Pending JP2019194220A (ja) 2013-11-22 2019-06-25 薬剤送達用のキャリア、コンジュゲートおよびこれらを含んでなる組成物並びにこれらの投与方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015548997A Expired - Fee Related JP6086566B2 (ja) 2013-11-22 2014-11-21 薬剤送達用のキャリア、コンジュゲートおよびこれらを含んでなる組成物並びにこれらの投与方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019116818A Pending JP2019194220A (ja) 2013-11-22 2019-06-25 薬剤送達用のキャリア、コンジュゲートおよびこれらを含んでなる組成物並びにこれらの投与方法

Country Status (6)

Country Link
US (2) US9937263B2 (enExample)
EP (1) EP3072506B1 (enExample)
JP (3) JP6086566B2 (enExample)
CN (2) CN105899192B (enExample)
CA (1) CA2931056C (enExample)
WO (1) WO2015075942A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3072506B1 (en) * 2013-11-22 2022-04-20 The University of Tokyo Carrier for drug delivery and conjugate, composition containing same, and method for administering same
JP6797415B2 (ja) * 2015-07-02 2020-12-09 国立大学法人 東京大学 薬剤送達用キャリア及びこれを含む組成物
EP3492512A4 (en) * 2016-07-30 2020-04-08 Nippon Kayaku Kabushiki Kaisha NEW POLYMER DERIVATIVES, AND NEW POLYMER DERIVATIVE IMAGING PROBE USING SAID NEW POLYMER DERIVATIVES
JP7043078B2 (ja) * 2016-09-23 2022-03-29 国立大学法人 東京医科歯科大学 血液脳関門通過型ヘテロ２本鎖核酸
US11364259B2 (en) * 2016-12-27 2022-06-21 The University Of Tokyo MRNA functionalization method
WO2018207864A1 (ja) * 2017-05-11 2018-11-15 公益財団法人川崎市産業振興財団 脳への薬剤送達用のキャリアおよびこれを含んでなる組成物
JPWO2019009434A1 (ja) * 2017-07-06 2020-07-02 学校法人京都薬科大学 薬物送達用高分子ミセル
JP2019069933A (ja) * 2017-10-05 2019-05-09 公益財団法人川崎市産業振興財団 体内における薬物動態を制御する組成物
WO2019181946A1 (ja) 2018-03-19 2019-09-26 国立大学法人東京医科歯科大学 毒性が軽減した核酸
JPWO2019240223A1 (ja) * 2018-06-13 2021-07-01 公益財団法人川崎市産業振興財団 数平均分子量が３ｋＤａ〜１０ｋＤａであるＰＥＧブロックとカチオン性ポリマーとのブロックコポリマーと、アンチセンスオリゴヌクレオチドとを含む、ポリイオンコンプレックスミセル
JPWO2020116635A1 (ja) * 2018-12-07 2021-10-21 国立大学法人 東京大学 輸送担体を用いた環状化合物の送達
JP7600101B2 (ja) 2019-04-26 2024-12-16 公益財団法人川崎市産業振興財団 抗体の抗原結合性断片を脳へ送達するための方法および組成物
WO2020230793A1 (ja) * 2019-05-13 2020-11-19 国立大学法人東京大学 血中からの中空ナノ粒子の脳への移行制御技術
WO2021193393A1 (en) * 2020-03-26 2021-09-30 Kawasaki Institute Of Industrial Promotion A method of administering a nanoparticle
WO2021207382A1 (en) * 2020-04-08 2021-10-14 The Johns Hopkins University D-glucose and its analogs as tracers to assess the glucose transporter function
US20250073349A1 (en) 2021-05-10 2025-03-06 Kawasaki Institute Of Industrial Promotion Antibody having reduced binding affinity for antigen
JP2024536844A (ja) * 2021-09-25 2024-10-08 ヌタリア リミテッド 処置様式のための標的封入戦略
WO2023210233A1 (ja) * 2022-04-27 2023-11-02 国立大学法人東海国立大学機構 糖連結ポリヌクレオチド
WO2025221757A1 (en) * 2024-04-15 2025-10-23 Board Of Regents, The University Of Texas System Carbohydrate-polymer conjugates for tunable protein binding on the blood brain barrier and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005076011A2 (en) * 2004-01-30 2005-08-18 Xenoport, Inc. Use of glut1 transporter expressed in blood brain barrier cells for screening for pharmacologically active substances
BRPI0619605B8 (pt) 2005-12-12 2021-05-25 Hoffmann La Roche composições compreendendo moléculas de anticorpos contra amilóide beta4 com glicosilação na região variável, usos das mesmas, método de preparação de uma molécula de anticorpo, e kit
US8765172B2 (en) * 2007-12-10 2014-07-01 Epitarget As Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids
UA104742C2 (uk) 2008-12-19 2014-03-11 Эли Лилли Энд Компани Похідні арилциклопропілацетаміду, застосовні як активатори глюкокінази
EP2382994A1 (en) * 2010-04-26 2011-11-02 Maurizio Victor Cattaneo Ligand targeted nanocapsules for the delivery of RNAi and other agents
JP5843763B2 (ja) 2010-05-21 2016-01-13 国立研究開発法人科学技術振興機構 物質内包ベシクル及びその製造方法
EP3072506B1 (en) * 2013-11-22 2022-04-20 The University of Tokyo Carrier for drug delivery and conjugate, composition containing same, and method for administering same

Similar Documents

Publication Publication Date Title
JP2017105802A5 (enExample)
Mishra et al. Lipid based nanocarriers: a translational perspective
Hao et al. Micelles of d-α-tocopheryl polyethylene glycol 2000 succinate (TPGS 2K) for doxorubicin delivery with reversal of multidrug resistance
JP6738376B2 (ja) 低減された投与容量を必要とする患者におけるベンダムスチン応答性症状の治療方法
Qu et al. Oral nanomedicine based on multicomponent microemulsions for drug-resistant breast cancer treatment
JP2011173928A5 (enExample)
JP2016528202A5 (enExample)
JP2011105792A (ja) ブロックコポリマー、ブロックコポリマー−金属錯体複合体、及びそれを用いた中空構造体キャリア
JP2013522212A5 (enExample)
JP2018528185A5 (enExample)
ES2971959T3 (es) Terlipresina para el tratamiento de la ascitis debida a cirrosis hepática administrada como una infusión continua
JP2013535422A5 (enExample)
Chen et al. Fabrication of a polysaccharide-protein/protein complex stabilized oral nanoemulsion to facilitate the therapeutic effects of 1, 8-cineole on atherosclerosis
Lu et al. FRET-based dual-emission and pH-responsive nanocarriers for enhanced delivery of protein across intestinal epithelial cell barrier
RU2017121203A (ru) НОВЫЕ ПОЛИМЕРНЫЕ hGH ПРОЛЕКАРСТВА
JP2018513188A5 (enExample)
JP2017522352A5 (enExample)
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
JP2019529541A5 (enExample)
JP2016027060A5 (enExample)
JP2016515623A5 (enExample)
Xin et al. Ophthalmic drops with nanoparticles derived from a natural product for treating age-related macular degeneration
JP2017014206A5 (enExample)
Han et al. Supramolecular engineering of molecular inhibitors in an adaptive cytotoxic nanoparticle for synergistic cancer therapy
Qi et al. Micelle system based on molecular economy principle for overcoming multidrug resistance and inhibiting metastasis